Related Experiment Video
Updated: Jul 18, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Surgical complications from hemostatic puncture closure devices
J F Eidt1, S Habibipour, J F Saucedo
1Department of Surgery, University of Arkansas for Medical Sciences and John L. McClellan VAMC, Little Rock, USA.
Insights
The Angio-Seal device for arterial puncture closure led to a significant increase in surgical repair for arterial occlusive complications. Surgeons need to understand these hemostatic devices to manage complications effectively.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Medical Device Technology
Background:
- The Food and Drug Administration has approved multiple hemostatic puncture closure devices for immediate hemostasis after percutaneous arterial catheterization.
- This study reviews institutional experience with the Angio-Seal device.
Purpose of the Study:
- To evaluate the safety and efficacy of the Angio-Seal hemostatic closure device.
- To assess the rate of vascular complications requiring surgical intervention after femoral cardiac catheterization using Angio-Seal compared to manual compression.
Main Methods:
- A retrospective, single-center, nonrandomized observational study.
- Inclusion of all patients undergoing femoral cardiac catheterization with either Angio-Seal device or routine manual compression.
- Analysis of vascular complications, including mechanical failures, arterial occlusion, stenosis, and embolization.
Main Results:
- The Angio-Seal device experienced immediate mechanical failure in 8% of patients.
- Surgical repair was required in 1.6% of patients following Angio-Seal use versus 0.3% with manual compression (P = 0.004).
- Five patients experienced femoral artery occlusion or stenosis due to the device; one patient had polymer anchor embolization.
Conclusions:
- The initial year of Angio-Seal utilization was associated with a significant rise in arterial occlusive complications necessitating surgical repair.
- Familiarity with the Angio-Seal device's design is crucial for surgeons to effectively manage associated surgical complications.
Background:
For securing immediate hemostasis following percutaneous arterial catheterization, the Food and Drug Administration has approved three hemostatic puncture closure devices. We reviewed our institutional experience with one device (Angio-Seal).
Methods:
A retrospective, single-center, nonrandomized observational study was made of all vascular complications following femoral cardiac catheterization.
Results:
An immediate mechanical failure of the device was experienced in 34 (8%) patients. Surgical repair was required in 1.6% (7 of 425) of patients following Angio-Seal versus 0.3% (5 of 1662) following routine manual compression (P = 0.004). In 5 patients, the device caused either complete occlusion or stenosis of the femoral artery. The polymer anchor embolized in 1 patient and was retrieved with a balloon catheter at surgery.
Conclusion:
During the first year of utilization of a percutaneous hemostatic closure device following cardiac catheterization, we observed a marked increase in arterial occlusive complications requiring surgical repair. Surgeons must be familiar with the design of these devices to achieve precise repair of surgical complications.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Aneurysm III: Interprofessional Care
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Hemodialysis II: Procedure and Complications
Healing II: Complications
Hemorrhagic Stroke ll: Pathophysiology

